SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SIBIA Neurosciences (SIBI)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (473)8/3/1999 12:29:00 AM
From: tommysdad  Read Replies (2) of 579
 
What's intriguing to me is: Why SIBI? Why MRK?

Merck's first big biotech acquisition is: a dinky little CNS company in La Jolla. Huh, what? A couple of ideas:

MRK is looking to open a facility in San Diego (Novartis, JNJ, and WLA all have one at this point) and this is a cheap way to do it. Who's next, and who would they buy?

MRK was "infringing" the SIBI patent and found one or more blockbuster drugs doing so. Buying the company outright was judged to be cheaper than paying royalties down the line. What other potential sleeper patents are out there?

SIBI pitched one of their programs/advanced compounds that impressed MRK so much they bought the company outright. But those are usually pretty public (see: SUGN & AGPH).

PeterSuzman suggested MRK/SIBI in March. What was the hook, Peter?

Maybe this belongs on the Munch thread, but this thread will be history soon anyway.

Kind of OT: Any guesses how many Merck/Rahway employees are going to be interested in becoming Merck/La Jolla employees?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext